Skip to main content

Jeff Jones

Stock Analyst at Oppenheimer

Total Price Targets
13
Stocks Covered
8
Sectors
Financial Services, Healthcare
Most Recent
Jan 6, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • ALMS+208.1%
    Alumis Inc. Common Stock
    $50.00 targetJan 6, 2026
  • KYMR+20.1%
    Kymera Therapeutics, Inc.
    $53.00 targetJun 27, 2025
  • KYMR+11.8%
    Kymera Therapeutics, Inc.
    $67.00 targetNov 4, 2025

Most Bearish

  • OPY-15.4%
    Oppenheimer Holdings Inc.
    $57.00 targetNov 14, 2025
  • KYMR+11.8%
    Kymera Therapeutics, Inc.
    $67.00 targetNov 4, 2025
  • KYMR+20.1%
    Kymera Therapeutics, Inc.
    $53.00 targetJun 27, 2025

Stocks Covered by Jeff Jones

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
ALMSAlumis Inc. Common Stock$50.00$25.27+97.8%1Jan 6, 2026
OPYOppenheimer Holdings Inc.$57.00$107.00-46.7%1Nov 14, 2025
KYMRKymera Therapeutics, Inc.$67.00$81.54-17.8%4Nov 4, 2025
PMVPPMV Pharmaceuticals, Inc.$6.00$1.38+334.8%1Nov 8, 2024
CATXPerspective Therapeutics, Inc.$22.00$3.90+464.8%3Oct 14, 2024
AVBPArriVent BioPharma, Inc. Common Stock$35.00$30.55+14.5%1Jul 22, 2024
PLRXPliant Therapeutics, Inc.$48.00$1.23+3818.4%1May 7, 2024
CRVSCorvus Pharmaceuticals, Inc.$7.00$15.49-54.8%1Aug 18, 2023

Recent Activity

  • Jan 6, 2026— Set$50.00price target onALMS(Alumis Inc. Common Stock)
  • Nov 14, 2025— Set$57.00price target onOPY(Oppenheimer Holdings Inc.)
  • Nov 4, 2025— Set$67.00price target onKYMR(Kymera Therapeutics, Inc.)
  • Jun 27, 2025— Set$53.00price target onKYMR(Kymera Therapeutics, Inc.)
  • Nov 8, 2024— Set$6.00price target onPMVP(PMV Pharmaceuticals, Inc.)
  • Oct 14, 2024— Set$22.00price target onCATX(Perspective Therapeutics, Inc.)
  • Sep 27, 2024— Set$56.00price target onKYMR(Kymera Therapeutics, Inc.)
  • Jul 22, 2024— Set$35.00price target onAVBP(ArriVent BioPharma, Inc. Common Stock)
  • Jun 18, 2024— Set$19.00price target onCATX(Perspective Therapeutics, Inc.)
  • May 15, 2024— Set$2.00price target onCATX(Perspective Therapeutics, Inc.)
  • May 7, 2024— Set$48.00price target onPLRX(Pliant Therapeutics, Inc.)
  • May 3, 2024— Set$52.00price target onKYMR(Kymera Therapeutics, Inc.)
  • Aug 18, 2023— Set$7.00price target onCRVS(Corvus Pharmaceuticals, Inc.)

Frequently Asked Questions

Who is Jeff Jones?

Jeff Jones is a stock analyst at Oppenheimer covering 8 stocks primarily in Financial Services, Healthcare. They have issued 13 price targets since Aug 18, 2023.

What stocks does Jeff Jones cover?

Jeff Jones currently covers 8 stocks, including KYMR, CATX, ALMS, OPY, PMVP.

What is Jeff Jones's latest price target?

Jeff Jones's most recent price target was $50.00 on ALMS (Alumis Inc. Common Stock), set on Jan 6, 2026.

What is Jeff Jones's highest price target?

Jeff Jones's highest issued price target is $67.00 on KYMR, set on Nov 4, 2025.

Coverage based on publicly published price targets. Not investment advice.